4d Pharma Plc - Warrants (22/02/2025) Net Tangible Assets

The latest net tangible assets for LBPSW is $32M as of December 2021. That compares with $28M in the prior-year period — up 15.9% year over year. Investors often review this figure alongside 4d Pharma Plc - Warrants (22/02/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LBPSW's net tangible assets moved from $28M to $32M — a 15.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 4d Pharma Plc - Warrants (22/02/2025)'s operating scale or balance-sheet position.

A net tangible assets figure of $32M for LBPSW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBPSW's net tangible assets ($32M), review year-over-year change from $28M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 4d Pharma Plc - Warrants (22/02/2025)'s net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.